Chronic stress promotes pancreatic ductal adenocarcinoma progression via complement C5a-recruited myeloid-derived suppressor cells
Year: 2025
Type: article
Language: en
Topic: Immune cells in cancer
Authors and affiliations:
raw_author_name: Siyuan Yang
raw_affiliation_strings: Jiaozuo Second People's Hospital, Jiaozuo, China
The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
raw_author_name: Li Xiao
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
West China Hospital of Sichuan University, Cancer Center, Chengdu, China
raw_author_name: Pingqian Qi
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Ziqing Liu
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Zhuomin Chen
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Ruijia Wei
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Ruishan He
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Qiwen Yu
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Zizhou Yan
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Suyi Xiong
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Mengmeng Wang
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Yanjuan Deng
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Jinping Hu
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Lv Zhou
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China
raw_author_name: Zhen Feng
raw_affiliation_strings: Rehabilitation Medicine Clinical Research Center of Jiangxi Province, Nanchang, 330003, Jiangxi, China. fengzhen@email.ncu.edu.cn
The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. fengzhen@email.ncu.edu.cn
raw_author_name: Huan Deng
raw_affiliation_strings: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Affiliated Rehabilitation Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. beandeng@ncu.edu.cn
Tumor Immunology Institute, Nanchang University, Nanchang, 330006, Jiangxi, China. beandeng@ncu.edu.cn